Development of a Ki-67-based clinical trial assay for neoadjuvant endocrine therapy response monitoring in breast cancer

PURPOSE: The recent publication of the ACOSOG Z1031 trial results demonstrated that Ki-67 proliferation marker-based neoadjuvant endocrine therapy response monitoring could be used for tailoring the use of adjuvant chemotherapy in ER+HER2-negative breast cancer patients. In this paper, we describe t...

Descripción completa

Detalles Bibliográficos
Autores principales: Goncalves, Rodrigo, DeSchryver, Katherine, Ma, Cynthia, Tao, Yu, Hoog, Jeremy, Cheang, Maggie, Crouch, Erika, Dahiya, Neha, Sanati, Souzan, Barnes, Michael, Sarian, Luis Otávio Zanatta, Olson, John, Allred, Donald Craig, Ellis, Matthew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543203/
https://www.ncbi.nlm.nih.gov/pubmed/28612227
http://dx.doi.org/10.1007/s10549-017-4329-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543203/
https://www.ncbi.nlm.nih.gov/pubmed/28612227
http://dx.doi.org/10.1007/s10549-017-4329-y

Ejemplares similares